Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

PCSK9 inhibitors

- PMLiVE

Amgen’s trebananib misses survival target in ovarian cancer

First phase III trial improved survival rates by just one month

- PMLiVE

Sanofi board votes out CEO Viehbacher

Unanimous decision ends weeks of speculation

- PMLiVE

Amgen should split up, says investor

Hedge fund manager Daniel Loeb criticises big biotech firm's 'bloated cost structure'

- PMLiVE

Amgen should split up, says investor

Hedge fund manager Daniel Loeb criticises big biotech firm's 'bloated cost structure'

- PMLiVE

Amgen appoints R Sanders Williams to board of directors

He is president of Gladstone Institutes

- PMLiVE

Regeneron top science employer, says survey

Ranked highest for third year in a row

- PMLiVE

Amgen files lawsuit to block PCSK9 rivals

Firm suing Sanofi and Regeneron for patent infringement

Sanofi reception

Sanofi to work with Immune Design on herpes vaccine

Both companies have separate vaccines in development but will pool resources

- PMLiVE

Awards recognise leading diabetes care in UK

QiC Diabetes celebrates work of NHS teams and individuals

Galapagos appoints Bart Filius as chief financial officer

He joins from Sanofi where he was CFO for Europe

Sanofi reception

Sanofi unit takes low-cost rotavirus vaccine into phase III

Licensed vaccines still too expensive for countries hit hardest

- PMLiVE

Sanofi looks to AstraZeneca for new UK & Ireland head

Tarja Stenvall replaces Steve Oldfield

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links